Abstract
Disrupted in Schizophrenia 1 (DISC1) is a schizophrenia risk gene associated with cognitive deficits in both schizophrenics and the normal ageing population. In this study, we have generated a network of protein–protein interactions (PPIs) around DISC1. This has been achieved by utilising iterative yeast-two hybrid (Y2H) screens, combined with detailed pathway and functional analysis. This so-called ‘DISC1 interactome’ contains many novel PPIs and provides a molecular framework to explore the function of DISC1. The network implicates DISC1 in processes of cytoskeletal stability and organisation, intracellular transport and cell-cycle/division. In particular, DISC1 looks to have a PPI profile consistent with that of an essential synaptic protein, which fits well with the underlying molecular pathology observed at the synaptic level and the cognitive deficits seen behaviourally in schizophrenics. Utilising a similar approach with dysbindin (DTNBP1), a second schizophrenia risk gene, we show that dysbindin and DISC1 share common PPIs suggesting they may affect common biological processes and that the function of schizophrenia risk genes may converge.
Introduction
Schizophrenia is a severe debilitating psychiatric disorder affecting ∼1% of the population worldwide. The disease can be separated into three domains: (1) positive symptoms, characterised by hallucinations, delusions, thought disorder and paranoia; (2) negative symptoms, which include anhedonia, social withdrawal and thought poverty; (3) cognitive symptoms, with dysfunction in attention, working memory and executive function.1 Current therapies are effective at treating positive symptoms but treatment of the negative and cognitive domains remain unmet medical needs.1
Although the aetiology of the disease remains unknown, several lines of evidence based on neuropathological, pharmacological and genetic data suggest that schizophrenia is a disease of the synapse.2 Post mortem and brain imaging studies of schizophrenics reveal neuroanatomical pathologies such as smaller neuropil size, decreased number of dendritic spines and arborisations,3, 4 abnormal neuronal migration and orientation,4, 5, 6 decreased number of synaptic proteins,7, 8 enlarged ventricles and decreased brain volumes.2, 9 These impairments suggest that abnormal or reduced synaptic connectivity may result from improper neurodevelopment culminating from an underlying genetic predisposition and/or early environmental insult.2, 10
Further evidence that schizophrenia is a disease of the synapse comes from observations that N-methyl-D-aspartate receptor (NMDAR) antagonists, PCP and ketamine, induce a broad range of schizophrenic like symptoms in normal individuals and exacerbates symptoms in affected patients.1 NMDA receptors also play a role in neuronal development and a transgenic mouse line, which has reduced expression of the NR1 subunit, has schizophrenic like behaviours.11, 12
Recent advances in psychiatric genetics have identified an increasing number of schizophrenia risk genes including Disrupted in Schizophrenia 1 (DISC1), neuregulin-1 (NRG1) and dysbindin (DTNBP1).2 Disruption of the DISC1 gene by a balanced (1;11) (q42;q14) translocation was originally reported to co-segregate with major psychiatric illnesses in a Scottish family.13 An increasing number of independent genetic studies have confirmed DISC1 as one of the most substantiated risk factors for schizophrenia.2 Interestingly, all carriers of the translocation exhibit reduced P300 event related potential, a measurement of attention-dependent information processing that has been consistently shown to be impaired in schizophrenic patients.14, 15 Furthermore, a cys704ser polymorphism located on exon 10 of DISC1 is associated with reduced hippocampal grey matter and NAA signal, as well as abnormal engagement of the hippocampus during several cognitive tasks assayed by fMRI.16 These observations suggest that DISC1 may participate in pathways important for cognitive function.15
The biological function of DISC1 remains poorly understood. However, recent reports that DISC1 interacts with Nudel (NDEL1) and PDE4B suggests roles for DISC1 in the regulation of neurodevelopmental and cAMP signalling pathways respectively.17, 18, 19, 20 These interactions are part of a larger effort to derive a network of DISC1 interactions, and were initially identified in the work described herein. Here, we report the ‘DISC1 Interactome’, which represents an interaction network consisting of 127 proteins and 158 interactions. Through detailed functional and pathway analysis, we provide evidence that DISC1 may be intimately linked to synapse function and that many of the proteins identified in our network are closely connected to genetic risk factors for schizophrenia such as dysbindin.2 We performed a further set of Y2H screens with dysbindin, a presynaptic protein,21 and have been able to show that it shares common protein–protein interactions (PPIs) with DISC1. This suggests even more strongly that there is the possibility of convergence in the biological function of schizophrenia risk genes, which may allow the identification of pathways that underlie the disease.
Materials and methods
Y2H library construction
Random cDNA libraries from human fetal brain poly(A+) RNA (20 weeks, ResGen Carlsbad, CA, USA) and human Adult brain poly(A+) RNA (Invitrogen: Discovery Line Human normal Brain mRNA, Sex: M, Age: 27, Catalog No: D6030-15, LOT No: A308079) were constructed in the pP6 plasmid derived from the original pACT222 and transformed in E. coli (DH10B; Invitrogen, Carlsbad, CA, USA). The complexity of the primary libraries was over 50 million clones. Sequence analysis was performed on 300 randomly chosen clones to establish the general characteristics of each library. The libraries were then transformed into yeast by classical lithium acetate protocol. Ten million independent yeast colonies were collected, pooled and stored at −80°C as equivalent aliquot fractions of the same library.22
Y2H bait plasmids
For C-terminal fusion, DISC1 was amplified using primers and cloned into a pLexA based plasmid (pBTM116 with minor modification) and a Gal4 based plasmid (pAS2ΔΔ with minor modification).22 For N-terminal fusion, DISC1 was cloned into a pLexA based N-terminal plasmid and in a Gal4 based N-terminal plasmid (pB23). pB23 was obtained by insertion in SacI−Pst1 of pAS2ΔΔ of two PCR products obtained using primers:
-
Gal4-5p: CGGGATTCGGT-GGTATGAAGCTACTGTCTTCTATCGAAC
-
Gal4-3p: TGCACTGC-AGTCACGGCGATACAGTCAACTGTCTTTG
-
ADH-5p: TTTGCGGCCGCCATGCATTT-ACTTATAATACAG
-
ADH-3p: CGCGAGCTCGAGATCCCGAGC from pAS2ΔΔ template.
All the constructs amplified by PCR have been fully sequenced using ABI 3700.
Two-hybrid screens were performed using a cell to cell mating protocol.22 For each bait, a test screen was performed to adapt the screening condition. The selectivity of the HIS3 reporter gene was eventually modulated with 3-aminotriazole (Sigma, St Louis, MO, USA) in order to obtain a maximum of 285 histidine-positive clones for 50 millions diploids screened. For all the selected clones, lacZ activity was estimated by overlay assay on solid media in 96-well plate format. Inserts of all positive clones were amplified by PCR22, 23 and then sequenced on an ABI 3700 automatic sequencer (Applied Biosystem, Foster City, CA, USA).22
Screens for both DISC1 and the truncated DISC1 were performed against both human fetal and adult brain libraries. All other screens were performed against fetal brain library only (Table 1).
Prey identification
5′ and 3′ sequences were determined for all positive clones in a screen. These were in turn filtered for quality using PHRED and ALU repeats were masked. Sequence contigs were built using CAP324 and searched against the latest release of GenBank using BLASTN.25
Identifying reliable interactions
Interactions were filtered based on a predicted biological score (PBS).22, 23, 26, 27 The PBS was calculated based on randomly sequenced cDNA library and adopts the conventional form of a P-value, where the smaller the PBS (P-value) the more significant. Briefly, a background distribution of the library is estimated by random sampling. The cDNA library will contain different genes as well as several fragments for a given gene (redundancy) that are of different lengths and may span different portions of a given gene (diversity: each fragment is independent of the other). Both the redundancy and the diversity of the library are used in order to determine the likelihood that a given prey will interact with the bait of choice by chance assuming that each fragment has an equal probability to interact with the bait. An initial expectation value is calculated based on the size of the library (i.e. number of transcripts) and on the number of overlapping fragments that are found to interact with the bait. The greater the number of overlapping fragments the greater the likelihood that the observed interaction is real and not a chance event. Fragments that are out of frame or antisense are discarded.
The topology of the network can also affect the final PBS score. The interactions identified are also examined in context of the whole network. For example, if two proteins that interact also share other common interactions, the likelihood that interactions are real increases and the PBS is adjusted accordingly. Conversely, if a given prey is identified in several different and independent screens, above an established threshold, it is considered to be a false positive interaction. The final PBS score reflects the probability that the interaction occurs by chance and is divided into the following arbitrarily derived categories A<1e-10<B<1e-5<C<1e-2.5 <D<1<E. The category E reflects sticky proteins that are found in several independent screens. The category D represents preys that only had one fragment identified. These may represent false positive interactions or may represent rare, low-copy number, transcripts in the library and require further validation. Interactions with PBS score in categories A–C are considered to be highly reliable.
Characterisation of over-represented biological themes
A 2 × 2 contingency table and Fisher's exact test were used to determine whether particular Gene Ontology (GO) terms,28 InterPro Domains,29, 30 SWISSPROT Keywords,31 and KEGG Pathways32 were disproportionately represented in a given set of PPIs assuming a hypergeometric distribution.29 The aim of this analysis is to determine if the observed frequencies (counts) in the set of interest (e.g. proteins that interact with DISC1) markedly differ from frequencies that would be expected by chance given a background distribution (i.e. human proteome or all genes expressed in the brain). Low P-values indicate that in the set of interest, a bias for a particular annotation (e.g. proteins belonging to microtubule based processes) is observed. GO terms for each gene were derived from Entrez Gene (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene), Proteome database (http://www.proteome.com/), and from InterPro domains. Annotation for each protein can be found in the Supplementary information.
A Monte Carlo simulation was also performed. We generated 1000 random networks each containing 127 brain expressed genes (the same number in the DISC1 network). For each of these random networks, over-represented biological process terms were identified as described above. A P-value for each of the observed terms in the DISC1 network was calculated as follows: Let n=biological process term with equal or better P-value in the random networks than observed (DISC1 network). Let m=total number of random networks.

Brain expressed genes were derived from unpublished in house data.
PPI resources
Where possible, previously reported interactions were included in the over-representation analysis. These were derived from Entrez gene entries and from MINT, BIND and IntAct, PPI databases.33, 34, 35 All interactions identified in this work have been deposited in the IntAct database (EBI-1104292 and EBI-1104295).35
PPI maps and matrix visualisation
PPI maps were generated using Cytoscape version 2.0.36 Matrices were generated using Matrix2Png.37
Derivation of schizophrenia risk loci
Cytogenetic location for each gene was derived from Entrez Gene and compared to risk schizophrenia risk loci as reported in Online Mendelian Inheritance in Man (OMIM) (www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=181500).
Cytogenetic locations of chromosomal aberrations linked to schizophrenia were derived from a number of previously published articles.20, 38, 39
Pathway information and mapping
Pathway information was obtained using Pathway Miner30 and Ingenuity, Inc. Pathway assist tool (www.ingenuity.com).
Results
DISC1 interacts with functionally diverse proteins
To assign a biological context for DISC1, a series of Y2H screens against human fetal and adult brain libraries were performed using the full-length DISC1 protein. Both GAL4 and LexA based Y2H screen methods were utilised, with different bait vectors containing either C-terminal or N-terminal fusion of the DNA binding domain (Table 1). The rationale behind screening both libraries with different vectors was to maximise the coverage of DISC1 interactors obtained and to increase our confidence in the reliability of the identified interactions.
A total of 289 interactors were identified in screens with the full length DISC1 protein. Of these, 34 were considered high-confidence interactions based on a method previously described23 whereby a PBS score is assigned reflecting the likelihood of the interaction. Highly significant PBS scores have been shown to correlate with biologically relevant interactions confirmed in the literature and by other experimental systems.20, 26, 27, 40 Filtering on probability of interactions has been successful in removing false positives interactions and has been used in several different studies to generate reliable protein interaction maps and to deduce novel biological findings.23, 26, 26, 40, 41
In order to determine major biological themes related to the set of DISC1 interacting proteins, over-representation of GO terms was determined28 (see Supplementary information). GO provides a set of terms used to describe gene products and is hierarchically divided into three main categories: biological processes, molecular function and cellular component. Biological processes are defined as one or more ordered assemblies of functions (e.g. cell growth and maintenance; pyrimidine metabolism). Cellular components refer generally to anatomical or macromolecular components in the cell (e.g. nucleus; ribosome complex). Molecular function corresponds to activity of gene products such as catalytic or binding activity (i.e. biochemical functions largely defined by the protein structure). The hierarchy of GO terms consists of more generic and less specific parent terms and more specific child terms. Using a cutoff of P<0.01, proteins that interact with DISC1 can be broadly associated with cytoskeletal organisation and biogenesis, mRNA/protein synthesis, cell cycle/division, intracellular transport and signal transduction processes. These broad categories are used for clarity and the significant and specific GO terms within these categories can be seen in Figure 2as well as in the Supplementary Tables. Many of these proteins are localised to cellular components such as microtubule organising centre, microtubule and actin cytoskeleton, centrosome and cell cortex consistent with published reports of DISC1 subcellular localisation.18, 42, 43 Proteins that interact with DISC1 have diverse functions and range from having enzymatic to structural roles. Over-represented molecular functions such as binding of cytoskeletal proteins, kinases and calmodulin suggest most of these proteins have a role in cell morphology through signal-transduction-mediated cytoskeletal organisation. Notably, many of these proteins such as Nudel, Lis1(PAFAH1B1), CDK5RAP3, the germinal center kinase TNIK and the Guanine exchange factor TRIO44, 45, 46, 47, 48 have been implicated in neurodevelopmental related processes, consistent with other protein interaction studies that implicate DISC1 in neurodevelopment.49 In addition, phosphodiesterase (PDE4B) and dystrophin (DMD) have been suggested to be important for cognitive function, deficits in which are a major component of schizophrenic symptomatology.50, 51
(a) Biological processes, (b) molecular functions, (c) cellular components and (d) protein families over-represented in the DISC1 network. Terms (rows) are ranked based on over-representation in the whole network using a cutoff of P<0.01 (Supplementary information). Shading highlights the number of proteins from each respective screen (columns) that belong to a given GO annotation or contain a particular InterPro domain (rows). White (no proteins) to blue (⩾5 proteins) in a given category per screen. Common themes were identified amongst each screen. Proteins that interact with DTNBP1 participate in the same processes as proteins in the DISC1 PPI network suggesting a convergent theme among these schizophrenia risk factors.
Experimental derivation of the DISC1 network of interactions
In order to derive a PPI network around DISC1, a series of second round Y2H screens were performed. Eight DISC1 interacting proteins were selected for subsequent screening against fetal brain library (Figure 1a; Table 1). These proteins represented each of the main processes described above such as cell cycle (CDC5L, CDK5RAP3), signal transduction (SH3BP5, TNIK), transport/localisation (Nudel, SEC3L1, TRAF3IP1) as well as those associated with the centrosome (Nudel and FLJ13386). For each screen, only interactions meeting our cutoff criteria discussed above were used for further analysis (Supplementary information). None of the identified interactions from the CDK5RAP3 screen met the cut off criteria. An additional screen was performed with the N-terminal portion of DISC1 (AA 1–350) in order to see if there were region specific protein interactions, given that this region lacks coiled-coil domains17 (Figure 1b).
(a) DISC1 network of PPIs. Underlined in red are proteins that interact with DISC1 and were used as baits in further Y2H screens to derive the protein interaction network. Blue connecting lines indicates an interaction between molecules that interact with at least two proteins in the network. In boxes are proteins that interact only with the bait protein screened. *(black) indicates proteins that are located in a schizophrenia risk locus. *(magenta) indicates proteins that are found in regions where chromosomal abnormalities have been linked to schizophrenia.36, 37 (b) Schematic of DISC1 full-length protein, its potential truncated form and the N-terminus region.
In total, including previously described DISC1 screens, over 1097 interactions were identified. Conservative filtering for potential false positives, as described previously, resulted in a network of 127 proteins and 158 interactions, with the vast majority of interactions being novel. Results from each screen were then combined in order to build a physical connectivity graph (Figure 1a). For protein annotation and details on the likelihood of each interaction, as described by the PBS, see Supplementary information. Common interactions between DISC1 and molecules used in the second round screens were identified (Figure 1a). For example, the synaptic protein spectrin (SPTBN1) was identified as an interacting protein to DISC1, CDC5L, FLJ13386(Cep63), TRAF3IP1 (MIP-T3), SH3BP5 and TNIK. KIAA1212, a protein predicted to be downstream of Wnt signalling, was identified in both Nudel and DISC1 screens. The presence of common interaction clusters suggests that these proteins are either in the same complex or are part of the same functional process in the cell.40, 41, 52, 53
Biological context of the DISC1 PPI network
As for DISC1, over-representation analysis of GO terms was determined for the derived network and for each individual screen (see Materials and methods). Most of the interactions identified for Nudel, TNIK, TRAF3IP1, CDC5L, SEC3L, FLJ13386 and SH3BP5 are novel. Nonetheless, the over-represented GO terms are in line with known biological processes and subcellular compartments to which these proteins have been associated and are consistent, as expected, with over-represented themes from the DISC1 set of interactions. Figure 2a–d illustrates the most significant biological processes, cellular components, molecular functions and protein domains for the network ranked by significance P<0.01 (over-represented themes for each individual screen can be found in Supplementary information). Proteins in the network share many common biological processes and subcellular localisation, suggesting greater confidence in the reliability of these interactions.40, 41, 52 Over-represented biological processes include regulation/organisation of actin and microtubule cytoskeleton, cell cycle/division and intracellular transport. Many of these processes are involved in dendritic/axonal morphology, synaptic connectivity, and communication. In terms of cellular components, most proteins are localised to the nucleus, actin/microtubule cytoskeleton, cell cortex, kinetochore, chromosome and cytoplasm. Molecular functions over-represented in the network suggest a bias in the network for proteins that are mainly involved in cytoskeletal regulation and stability.
The fact that proteins in our network share common interactions as well as biological processes, strongly suggests that these interactions are real as opposed to random. Nonetheless, in order to test whether a random sample of brain expressed genes would contain the same biases as our network, we generated 1000 random networks each consisting of 127 proteins. Brain expressed genes were derived from unpublished in-house microarray data. The null assumption is that randomly selected genes that are expressed in the brain can be arranged in a similar network and with the same biases in biological processes as observed in the DISC1 network (e.g. cytoskeleton). For each respective random network, we determined the over-represented themes as described and calculated the number of times a biological process term identified in the random set was equally or more significant than the values identified in the DISC1 network (see Materials and methods). Table 2 shows the P-value for each biological process term in our network suggesting that our observations are not random and due to an intrinsic brain bias. These observations also highlight that the clustering of functional groups in our network is not random and enforces the PBS for the protein interactions. Furthermore, this observation confirms previous findings that, as expected, proteins form functional modules in interaction networks.53, 54, 55, 56
The DISC1 interactome suggests a role for DISC1 in synapse development
If DISC1 is to have an effect on cognitive processes and synaptic pathology, then it must do so by affecting genes or pathways that are implicated in neurodevelopment and plasticity such as BDNF, Wnt and Reelin, and the regulation of members of the RhoGTPase family.2, 41 In order to test this hypothesis, we searched the literature and protein–protein interaction/pathways databases in order to see if proteins in our network were involved in critical processes of synapse development, formation and maturation. In addition to the well-documented interactions with Lis1, Nudel and FEZ1, which implicate DISC1 in neuronal migration, many of the proteins in our network are involved in pathways critical for the formation of synapses namely synaptic activity mediated by the glutamatergic AMPAR and NMDAR receptor complexes, dendritic–axonal contact (e.g. Integrins, receptor tyrosine kinases, Cadherins), glial secreted factors (e.g. TNF-α and Wnt), regulation of actin dynamics (e.g. regulation of RhoGTPases by SRGAP3,KARLN, TRIO and SOS1), cytoskeletal stability (e.g. microtubule and dendritic stability: spectrins, ankyrin, microtubule crosslinking factors and neurofilament proteins), intracellular transport (e.g. dendritic targeting of mRNA, proteins and glutamate receptors), neuronal polarity and migration (e.g. reelin, Robo-slit signalling pathways), dendritic growth and branching by neurotrophic factors via Trk and EGF receptors (e.g. SOS1 and SNX6), gene expression (e.g. NCOR2 and AOF2), proteins synthesis (e.g. EIF3S3 and EEF2) and neuronal apoptosis (e.g. JNK signalling cascade, CLU, SH3BP5, PPP1R13B, RAD21) (Figure 3a–d).41, 42, 43, 44, 45, 46, 47, 48, 49 These are all processes that are critical for the development, maturation and plasticity of synapses, and which may also be linked to schizophrenia-related neuropathologies.57, 58, 59, 60, 61, 62, 63, 64, 65 Furthermore, a recent publication has systematically identified genes required for synapse structure in function in Caenorhabditis elegans neuromuscular junction.66 Proteins in our network identified in this study include SOS1, DMD, SPTAN1 and YWHAZ.66
Potential relationship between the DISC1 network and synapse development. Schematic diagram showing sections of the DISC1 interactome that show evidence of a connection between DISC1 and key processes involved in synapse development/maturation, which in turn may underline observed neuroanatomical pathologies in schizophrenia. (a) DISC1 interacts with proteins involved in key processes involved in the proper formation of synapses. Deficits in these processes may underlie decreased dendritic branching, arborisations and neuropil size observed pathologically.3, 4 (b) DISC1 interacts with proteins involved in both retrograde (dyenin associated) and anterograde (kinesin associated) transport as well as components of the exocyst complex, which are important for the trafficking of glutamate receptors. Deficits in these processes may result in a decrease in the number of synaptic proteins seen in schizophrenics.8, 74 (c) DISC1 interacts with proteins downstream of neuronal migration signalling pathways. Deficits in these pathways could result in the disarray of neuronal orientation and abnormal axon projections seen in schizophrenics.5, 6 (d) Glial secreted factors such as Wnt and TNF-α also play an important role in synaptogenesis.58
Potential implications of the DISC1(1;11) translocation
The translocation leading to the disruption of the DISC1 gene in the Scottish family may result in haploinsufficiency or in the production of a truncated protein product.67 A truncated protein may gain and/or lose certain protein interactions, in doing so it may act in a dominant-negative manner. In order to explore these potential outcomes, we screened both adult and fetal brain libraries using the putative truncated form (AA1–527) of the protein (Figure 4 and 1b). As described previously, we selected 31 high confidence interactions of truncated DISC1 and identified the proteins that may potentially contribute to each of the scenarios as described above (Figure 4). Using proteins from each set, we mapped them to their equivalent GO categories to see what processes, molecular functions and cellular components are affected due to translocation (see Supplementary information). Interestingly, some of the processes affected by the loss of function are also affected by the gain of function such as proteins involved in microtubule-based processes, cell division, actin dynamics, Rho protein signal transduction and cytoskeleton-dependent intracellular transport (see Supplementary information).
Representation of the potential effects of the (1;11) translocation on the DISC1 interactome. The translocation may result in haploinsufficiency or in the production of a truncated protein product.67 A truncated protein may gain and/or lose certain protein interactions, in doing so it may act in a dominant-negative manner. Haploinsufficiency: DISC1 protein is not expressed. Loss/Gain of function: the loss of the C-terminus results may result in the ability of DISC1 to interact with new partners as well as lose C-terminal dependent protein interactions. Furthermore, the dominant-negative form may compete for binding with wild type form. It is not known whether the truncated protein is expressed in patients with the translocation.
We also performed screens with the N-terminal portion of DISC1 (Figure 1b), where we expected to identify similar interaction partners to the truncated protein. Interestingly, there was little overlap between these screens, only six interactions in common, indicating that the additional 177 AA found in the truncated protein, which contains coiled-coil regions, may interfere with proteins that bind to the N-terminal region of DISC1.
Most of the processes previously described relating to synapse formation could be affected by loss and gain of interactions. However, the loss and gain of interactions as a result of truncation described here could be related to screen efficiency as well as to the choice of vectors used. Therefore, these differences need to be further validated in other experimental systems. Nonetheless, these observations highlight potential regions of interaction within the DISC1 protein and suggest that the C-terminal portions of the protein may constrain or interfere with proteins that interact with the N-terminal region.
Schizophrenia risk genes share common protein interactions
Several proteins in our network are in schizophrenia-associated loci, as defined by OMIM, or are in regions of documented chromosomal aberrations linked to schizophrenia (Figure 1a) suggesting that DISC1 and other risk genes may converge on similar biological processes. Given this observation, it was important to see if we could link proteins identified in the DISC1 network to other genes implicated in schizophrenia. To this end, additional Y2H screens with another major schizophrenia risk gene DTNBP1 (Table 1)2 was conducted. These screens identified 17 high confidence interactors (Table 1; Figure 5). Intriguingly, like DISC1, dysbindin interacts with microtubule crosslinking factors MACF1 and DST (Figure 5). Dysbindin also shares common interactions with other proteins in our network such as SEC3L1 (exocyst complex), CDC5L (cell cycle regulation), TNIK (germinal center kinase) and TRAF3IP1 (protein associated with cytokine signalling) (Figure 1a). As described, GO over-representation analysis was performed in the dysbindin set of protein interactions. Similar themes as identified in the DISC1 interactome were found in the set of dysbindin interactions such as cell division, microtubule organisation and biogenesis, axon cargo transport and exocytosis (Figure 3a–d).
Two major schizophrenia risk factors, DISC1 and DTNBP1, share common interactions. Dysbindin shares common PPIs with DISC1 and other proteins in the DISC1 network (red edges). DST and MACF1 are microtubule crosslinking factors that interconnect all three cytoskeletal filament networks: actin and intermediate filaments as well as microtubules. Both DISC1 and dysbindin also interact with members of the exocyst complex, which are involved in the transport of glutamate receptors. In addition to sharing common protein interactions with DISC1, dysbindin interacts with proteins in similar biological processes that were enriched in the DISC1 network (see Figure 2).
Discussion
In this study, we have generated a network of PPIs around a schizophrenia risk factor, DISC1, in order to identify potential pathways affected by this protein that in turn may be central for understanding the molecular pathology of schizophrenia. Not only have we identified a large number of novel interacting partners for DISC1, we have also found a plethora of previously unknown interactions for seven of its direct interactors. Through this iterative set of yeast-two hybrid screens, in combination with literature and pathway database mining, we have further implicated DISC1 in the neurodevelopmental hypothesis of schizophrenia2, 10, 67 while for the first time providing evidence from our network that DISC1 is likely to participate in synapse formation and maturation,57, 58, 59, 60, 61, 62, 63, 64, 65 potentially as a key ‘hub’ protein in these processes.40
To date, several lines of evidence implicate DISC1 not only in schizophrenia but also in cognition.16, 68, 69 In vitro, in vivo and clinical data suggest that deficits in DISC1 could result in abnormal neuronal migration, faulty dendritic development and synapse maturation, and thus ultimately cognitive deficits. DISC1 has been localised to dendritic spines and overexpression of the putative truncated form resulted in abnormal neurite outgrowth.19 Work by Kamiya et al.70 shows that in utero RNAi depletion of DISC1 (analogous to haploinsufficiency model) results in abnormal neuronal migration, thinning of dendritic spines, as well as decreased number of dendritic arborisations. The effect of the (1;11) translocation at the behavioural level has been more compelling with all carriers presenting measurable cognitive deficits.15 Furthermore, polymorphisms in the DISC1 gene have been associated with poorer performance in neurocognitive tasks in schizophrenics, and lower cognitive ability in the normal aging population.16, 68, 69 Although it is not yet known whether any (1;11) translocation carriers exhibit synaptic pathologies, such as reduced number of dendrites or abnormal connectivity, the DISC1 interactome, derived in this study, suggests that abnormalities in the DISC1 protein could have repercussions for biological processes critical for synapse development/maturation, biochemical signalling and hence cognitive performance (Figure 3a–d).
The consequence of the (1;11) translocation at the protein level for DISC1 is still unknown and the presence of a truncated protein has not been confirmed in the Scottish (1;11) family. Nonetheless, studies using the truncated DISC1 protein may provide an informative model to understand the underlying pathology. Using our network, we would predict perturbation of a common set of biological processes whether a truncated protein is produced or a haploinsufficiency model occurs. This would principally involve proteins involved in cytoskeletal stability and organisation, intracellular transport and cell-cycle/division. Intriguingly, this is supported by in vivo overexpression of truncated DISC1 (analogous to production of truncated DISC1) results in a very similar phenotype of defective neuronal migration.70
Is there a convergence in processes affected by schizophrenia risk factors? Recent evidence has demonstrated that proteins within the same disease are more likely to interact or belong to the same functional modules in biological networks.71 Many proteins in the DISC1 network are in a chromosomal region associated with schizophrenia or associated, through pathway analysis, with proteins implicated in schizophrenia indicating that DISC1 may interact with and/or participate in the same biological processes as other schizophrenia risk factors (Figures 1, 2 and 5). Interestingly, dysbindin, another major schizophrenia risk factor (2; 21) shares common protein interactions with DISC1. Both DISC1 and dysbindin interact with the microtubule crosslinking factors dystonin (DST/BPAG1) and microtubule-actin crosslining factor 1 (MACF1) (Figure 5). These microtubule crosslinking factors, also known as plankins, interconnect all three cytoskeletal filament networks: actin filaments, microtubules and intermediate filaments. Reduction in dendritic branching is observed in MACF1 (kakapo) mutants in Drosophila and variants of DST have been shown to be essential for neuronal survival. Furthermore, DST deficient neurons are defective in axonal transport due to unstable and disorganised microtubules.72, 73 Both DISC1 and dysbindin also interact with members of the exocyst complex, which play a role in trafficking of glutamate receptors to synaptic terminals and it would be interesting to see how deficits on either of these proteins will affect glutamatergic transmission and receptor density (Figures 1a and 3b). These observations suggest that both DISC1 and dysbindin may affect structure and function of synapses by disruption of intracellular transport and cytoskeletal stability. These findings also highlight that the increasing set of schizophrenia risk genes may actually converge functionally on a more rational set of processes, which may contribute to the observed deficits in connectivity observed in schizophrenic patients.2, 71 This would be of great value to the psychiatric research community as it starts to make sense of this ever increasing number of candidates.
There are many challenges involved in the analysis of protein interaction networks. First, is the careful consideration and reliability in the observed interactions. In order to account for potential false positives, we adhered to a stringent set of criteria that relied on the likelihood of interactions being observed by chance given the distribution of the cDNA library. Furthermore, many of the proteins in our network share common interactions suggesting the presence of interaction clusters, which would not occur in a random network.56 The consistency in protein annotation across all screens indicate that these proteins belong to common biological processes and therefore suggests that the network is organised and non-random consistent with previous findings.53, 54, 55 In order to test this, we showed that (1) proteins in our network are biased to the same biological processes when comparing to a background distribution of brain expressed genes and (2) randomly generated networks of brain expressed genes are not biased to the same biological processes observed in the DISC1 network. However, many proteins in the network are of unknown function and therefore other biological properties may have been overlooked. Furthermore, many of these interactions may be brain region specific, cellular compartment dependent and/or favoured under a particular stimulus. In addition, interactions also need to be characterised in spatial and temporal contexts. There is already a precedent with DISC1 for interactions to be under developmental control as shown by the transient interaction with Nudel.17
In generating this network of PPIs around DISC1, we provide a rich data set that can be used by a wider audience to guide their research into not only DISC1 but schizophrenia more generally. For example, previously reported DISC1 interactions such as those to Nudel, Lis1 and PDE4B were originally derived from the screens described in this work and have been subsequently substantiated in vivo.17, 20 It will be critical to expand this experimental set to many of the novel interactions identified in this present study. We hope that we have provided for the first time a molecular framework by which the mechanisms of schizophrenia can be unravelled, using DISC1 as our key protein landmark. Moreover, the data set may allow the field to move away from receptor-based therapy to potentially more focused intracellular therapeutic targets.
References
Tamminga CA, Holcomb HH . Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 2005; 10: 27–39.
Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2004; 20: 40–68.
Glantz LA, Lewis DA . Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65–73.
Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R . NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) 2003; 169: 215–233.
Benes FM, Majocha R, Bird ED, Marotta CA . Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry 1987; 44: 1017–1021.
Kovelman JA, Scheibel AB . A neurohistological correlate of schizophrenia. Biol Psychiatry 1984; 19: 1601–1621.
Eastwood SL, Burnet PW, Harrison PJ . Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66: 309–319.
Deakin JF, Simpson MD . A two-process theory of schizophrenia: evidence from studies in post-mortem brain. J Psychiatr Res 1997; 31: 277–295.
Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS et al. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 1999; 7: 125–143.
Lewis DA, Levitt P . Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002; 25: 409–432.
Mohn AR, Gainetdinov RR, Caron MG, Koller BH . Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98: 427–436.
Stefani MR, Moghaddam B . Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 2005; 57: 433–436.
Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–1423.
Braff DL, Light GA . Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) 2004; 174: 75–85.
Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ . Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69: 428–433.
Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci 2005; 102: 8627–8632.
Brandon NJ, Handford EJ, Schurov I, Rain JC, Pelling M, Duran-Jimeniz B et al. Disrupted in schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 2004; 25: 42–55.
Morris JA, Kandpal G, Ma L, Austin CP . DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 2003; 12: 1591.
Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 2003; 100: 289–294.
Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005; 310: 1187–1191.
Arnold SE, Talbot K, Hahn CG . Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 2005; 147: 319–345.
Fromont-Racine M, Rain JC, Legrain P . Building protein–protein networks by two-hybrid mating strategy. Methods Enzymol 2002; 350: 513–524.
Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S et al. The protein–protein interaction map of Helicobacter pylori. Nature 2001; 409: 211–215.
Huang X, Madan A . CAP3: A DNA sequence assembly program. Genome Res 1999; 9: 868–877.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ . Basic local alignment search tool. J Mol Biol 1990; 215: 403–410.
Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A et al. Functional proteomics mapping of a human signaling pathway. Genome Res 2004; 14: 1324–1332.
Formstecher E, Aresta S, Collura V, Hamburger A, Meil A, Trehin A et al. Protein interaction mapping: a Drosophila case study. Genome Res 2005; 15: 376–384.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25–29.
Liu S, Altman RB . Large scale study of protein domain distribution in the context of alternative splicing. Nucleic Acids Res 2003; 31: 4828–4835.
Mulder NJ, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D et al. InterPro, progress and status in 2005. Nucl Acids Res 2005; 33 (Suppl_1): D201–D205.
Bairoch A, Boeckmann B . The SWISS-PROT protein sequence data bank. Nucleic Acids Res 1991; 19 (Suppl): 2247–2249.
Kanehisa M . The KEGG database. Novartis Found Symp 2002; 247: 91–101.
Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M, Cesareni G . MINT: a Molecular INTeraction database. FEBS Lett 2002; 513: 135–140.
Bader GD, Betel D, Hogue CW . BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 2003; 31: 248–250.
Hermjakob H, Montecchi-Palazzi L, Lewington C, Mudali S, Kerrien S, Orchard S et al. IntAct: an open source molecular interaction database. Nucleic Acids Res 2004; 32 (Database issue): D452–D455.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498–2504.
Pavlidis P, Noble WS . Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003; 19: 295–296.
MacIntyre DJ, Blackwood DH, Porteous DJ, Pickard BS, Muir WJ . Chromosomal abnormalities and mental illness. Mol Psychiatry 2003; 8: 275–287.
Demirhan O, Tastemir D . Chromosome aberrations in a schizophrenia population. Schizophr Res 2003; 65: 1–7.
Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H et al. A human protein–protein interaction network: a resource for annotating the proteome. Cell 2005; 122: 957–968.
Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y et al. A protein interaction map of Drosophila melanogaster. Science 2003; 302: 1727–1736.
Brandon NJ, Schurov I, Camargo LM, Handford EJ, Duran-Jimeniz B, Hunt P et al. Subcellular targeting of DISC1 is dependent on a domain independent from the Nudel binding site. Mol Cell Neurosci 2005; 28: 613–624.
James R, Adams RR, Christie S, Buchanan SR, Porteous DJ, Millar JK . Disrupted in schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci 2004; 26: 112–122.
Toyo-oka K, Shionoya A, Gambello MJ, Cardoso C, Leventer R, Ward HL et al. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller–Dieker syndrome. Nat Genet 2003; 34: 274–285.
Reiner O, Cahana A, Escamez T, Martinez S . LIS1-no more no less. Mol Psychiatry 2002; 7: 12–16.
Bateman J, Van Vactor D . The Trio family of guanine-nucleotide-exchange factors: regulators of axon guidance. J Cell Sci 2001; 114: 1973–1980.
Fu CA, Shen M, Huang BCB, Lasaga J, Payan DG, Luo Y . TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J Biol Chem 1999; 274: 30729–30737.
Wang X, Ching YP, Lam WH, Qi Z, Zhang M, Wang JH . Identification of a common protein association region in the neuronal Cdk5 activator. J Biol Chem 2000; 275: 31763–31769.
Millar JK, Christie S, Porteous DJ . Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem Biophys Res Commun 2003; 311: 1019–1025.
Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM . Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 2000; 23: 198–204.
Bresolin N, Castelli E, Comi GP, Felisari G, Bardoni A, Perani D et al. Cognitive impairment in Duchenne muscular dystrophy. Neuromuscul Disord 1994; 4: 359–369.
Lehner B, Fraser AG . A first-draft human protein-interaction map. Genome Biol 2004; 5: R63.
Spirin V, Mirny LA . Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci USA 2003; 100: 12123–12128.
von Mering C, Zdobnov EM, Tsoka S, Ciccarelli FD, Pereira-Leal JB, Ouzounis CA et al. Genome evolution reveals biochemical networks and functional modules. Proc Natl Acad Sci USA 2003; 100: 15428–15433.
Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL . Hierarchical organization of modularity in metabolic networks. Science 2002; 297: 1551–1555.
Barabasi AL, Oltvai ZN . Network biology: understanding the cell's functional organization. Nat Rev Genet 2004; 5: 101–113.
Whitford KL, Dijkhuizen P, Polleux F, Ghosh A . Molecular control of cortical dendrite development. Annu Rev Neurosci 2002; 25: 127–149.
Li Z, Sheng M . Some assembly required: the development of neuronal synapses. Nat Rev Mol Cell Biol 2003; 4: 833–841.
Lamprecht R, LeDoux J . Structural plasticity and memory. Nat Rev Neurosci 2004; 5: 45–54.
Kennedy MB, Beale HC, Carlisle HJ, Washburn LR . Integration of biochemical signalling in spines. Nat Rev Neurosci 2005; 6: 423–434.
Ziv NE, Garner CC . Cellular and molecular mechanisms of presynaptic assembly. Nat Rev Neurosci 2004; 5: 385–399.
Collingridge GL, Isaac JT, Wang YT . Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 2004; 5: 952–962.
Klann E, Dever TE . Biochemical mechanisms for translational regulation in synaptic plasticity. Nat Rev Neurosci 2004; 5: 931–942.
Sandi C . Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 2004; 5: 917–930.
Cbelos B, Gimenez C, Zafra F . The glycine transporter GLYT1 interacts with Sec3, a component of the exocyst complex. Neuropharmacology 2005; 20: 935–944.
Sieburth D, Ch'ng Q, Dybbs M, Tavazoie M, Kennedy S, Wang D et al. Systematic analysis of genes required for synapse structure and function. Nature 2005; 436: 510–517.
Sawa A, Snyder SH . Genetics. Two genes link two distinct psychoses. Science 2005; 310: 1128–1129.
Thomson PA, Harris SE, Starr JM, Whalley LJ, Porteous DJ, Deary IJ . Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neuroscience Lett 2005; 389: 41–45.
Burdick KE, Hodgkinson CA, Szeszko PR, Lencz T, Ekholm JM, Kane JM et al. DISC1 and neurocognitive function in schizophrenia. Neuroreport 2005; 16: 1399–1402.
Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005; 7: 1067–1078.
Gandhi TK, Zhong J, Mathivanan S, Karthick L, Chandrika KN, Mohan SS et al. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat Genet 2006; 38: 285–293.
Leung CL, Sun D, Zheng M, Knowles DR, Liem RK . Microtubule actin cross-linking factor (MACF): a hybrid of dystonin and dystrophin that can interact with the actin and microtubule cytoskeletons. J Cell Biol 1999; 147: 1275–1286.
Yang Y, Bauer C, Strasser G, Wollman R, Julien JP, Fuchs E . Integrators of the cytoskeleton that stabilize microtubules. Cell 1999; 98: 229–238.
Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ . Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 1995; 29: 211–223.
Acknowledgements
We thank Dr Miles Houslay and Dr Cem Elbi for input and discussions, Gianni Ceasareni and Luisa Montecchi-Palazzi for kindly providing us with releases of the MINT database, and Sue Ellis for kindly providing the figures for this work.
Author information
Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
Rights and permissions
About this article
Cite this article
Camargo, L., Collura, V., Rain, JC. et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry 12, 74–86 (2007). https://doi.org/10.1038/sj.mp.4001880
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001880
Keywords
- synapse
- schizophrenia
- neurodevelopment
- dysbindin
- DISC1
- cognition
Further reading
-
ZFP804A mutant mice display sex-dependent schizophrenia-like behaviors
Molecular Psychiatry (2021)
-
Autoantibody profiles associated with clinical features in psychotic disorders
Translational Psychiatry (2021)
-
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders
Molecular Psychiatry (2021)
-
Structural interaction between DISC1 and ATF4 underlying transcriptional and synaptic dysregulation in an iPSC model of mental disorders
Molecular Psychiatry (2021)
-
Disrupted-in-schizophrenia 1 enhances the quality of circadian rhythm by stabilizing BMAL1
Translational Psychiatry (2021)




